There are many general counsel taking new positions for the start of 2014, and many of those switches have been planned for a long time. But one major company comes in late with a surprise GC shift at the end of the year — pharmaceutical giant Pfizer.
Pfizer GC Amy Schulman has announced she is leaving the company. Previously, she was supposed to step into a role as head of Pfizer’s new Vaccines, Oncology and Consumer Healthcare division. But instead, in a statement issued Dec. 17, it was announced she would be leaving all of her roles, including GC and her spot on the executive board, effective immediately.